Back to search
FDAFDA · Food and drugs·Recall number D-0326-2023

Humatrix Microclysmic Gel, 8 oz per bottle, Care-Tech Laboratories, Inc., Saint Louis, Missouri 63139.

Published February 22, 2023 · Recall initiated: January 10, 2023

Summary

FDA records drug Class II recall D-0326-2023, published February 22, 2023 and initiated January 10, 2023. Recalling firm: Consolidated Chemical, Inc; Status: Ongoing; Reported quantity: 3186 bottles; Lot: Lot, expiry: Lot 3216, exp 04/23 and 3218, exp 10/23. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: initiated due to violations of CGMP manufacturing practices

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Consolidated Chemical, Inc
Distributor
Nationwide in the USA
Lot
Lot, expiry: Lot 3216, exp 04/23 and 3218, exp 10/23
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Humatrix Microclysmic Gel, 8 oz per bottle, Care-Tech Laboratories, Inc., Saint Louis, Missouri 63139. recalled?

Yes. FDA published recall D-0326-2023 on February 22, 2023. Reported hazard: CGMP Deviations: initiated due to violations of CGMP manufacturing practices

What should I do if I have this product?

Voluntary: Firm initiated · Letter